LON:IBT

International Biotechnology (IBT) Share Price, News & Analysis

International Biotechnology logo
GBX 1,034.10 -30.90 (-2.90%)
As of 11:51 AM Eastern

About International Biotechnology Stock (LON:IBT)

Advanced

Key Stats

Today's Range
1,030
▼
1,065
50-Day Range
994
▼
1,125
52-Week Range
842
▼
1,235
Volume
28,575 shs
Average Volume
69,760 shs
Market Capitalization
£327.32 million
P/E Ratio
4.28
Dividend Yield
2.94%
Price Target
N/A
Consensus Rating
N/A

Company Overview

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services. While the Company’s portfolio is held as one pool of assets, for operational purposes there is a quoted portfolio and an unquoted portfolio. The portfolio is diversified by geography, industry sub-sector and investment size with no single investment in a company normally accounting for more than 15% of the portfolio at the time of investment. The portfolio is split between large, mid and small-capitalisation companies, primarily quoted on stock exchanges in North America, where the most established and commercial biotech and other life sciences companies and companies operating in related sectors are based, though investments will also be made in Europe, Asia and Australia. Investments may also be made into unquoted companies and into funds not quoted on a stock exchange, including venture capital funds. This may include funds managed by the Investment Manager and/or members of its group. The primary purpose of investment in unquoted funds will be to gain exposure to unquoted companies. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Forward or derivative transactions are not used by the Company. The Company may borrow from time to time to exploit specific investment opportunities, rather than to apply long-term structural gearing to the Company’s portfolio of investments.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IBT Stock News Headlines

Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

International Biotechnology's stock was trading at GBX 964 at the start of the year. Since then, IBT stock has increased by 7.3% and is now trading at GBX 1,034.10.

International Biotechnology (LON:IBT) issued its earnings results on Tuesday, November, 3rd. The company reported GBX (10.22) EPS for the quarter. The company earned £460 thousand during the quarter. International Biotechnology had a trailing twelve-month return on equity of 44.12% and a net margin of 95.99%.

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Finsbury Growth & Income (FGT), Legal & General Group (LGEN), Polar Capital Technology Trust (PCT), ACADIA Pharmaceuticals (ACAD), Advanced Micro Devices (AMD), Arista Networks (ANET) and abrdn (ABDN).

Company Calendar

Last Earnings
11/03/2026
Today
11/17/2026

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Finance
Industry
Capital Markets
Sub-Industry
Asset Management & Custody Banks
Current Symbol
LON:IBT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 241.73
Trailing P/E Ratio
4.28
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£37.91 million
Net Margins
95.99%
Pretax Margin
N/A
Return on Equity
44.12%
Return on Assets
3.57%

Debt

Debt-to-Equity Ratio
5.90
Current Ratio
0.11
Quick Ratio
0.32

Sales & Book Value

Annual Sales
£78.01 million
Price / Sales
4.20
Cash Flow
GBX 6.64 per share
Price / Cash Flow
155.74
Book Value
GBX 766.24 per share
Price / Book
1.35

Miscellaneous

Outstanding Shares
31,653,000
Free Float
N/A
Market Cap
£327.32 million
Optionable
Not Optionable
Beta
0.47
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (LON:IBT) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners